Recently Appointed Professors

Professors introduced at the December 2014 Faculty of Medicine meeting.

Please click here to view event photos from previous Faculty of Medicine meetings and the most recent December 18, 2014 meeting.

Todd M. Allen | Shalender Bhasin | David F.M. Brown | Hyon K. Choi | Lyn McDivitt Duncan | Albert Edge | Leif Ellisen | Laurence M. Epstein | Alison E. Field | Lisa V. Goodrich | Eva C. Guinan | Francis J. Hornicek, Jr. | Grant L. Iverson | Ashish K. JhaS. Ananth Karumanchi | Scott G. Kennedy | Ali Khademhosseini | Lori Laffel | Beate K.M. Lanske | Elena Losina | Richard Malley | Madhusmita Misra | Orhun Muratoglu | Phillip L. Pearl | Olivier Pourquié | Eric B. Rimm | David C. Ring | James R. Rodrigue | Evan Rosen | David Z. Rudner | Jeremy N. Ruskin | Steven D. Schwaitzberg | Magdy H. Selim | Ramesh A. Shivdasani | Shamil R. Sunyaev | Brooke Swearingen | Sapna Syngal | William (Sandy) Wells, III


Todd M. Allen

Dr. Allen is Professor of Medicine at Massachusetts General Hospital and serves as the Deputy Director of the Ragon Institute of MGH, MIT and Harvard. His work characterizing the sequence evolution of HIV and Hepatitis C virus has provided novel insight into the mechanisms by which these pathogens evade host immunity and identified critical targets for vaccine design. Recent work by his group is focused on the development of humanized mice to further vaccine development against these highly persistent human pathogens.

Return to Top


Shalender Bhasin

Dr. Bhasin is Professor of Medicine at Brigham and Women’s Hospital. He investigates reproductive endocrinology and aging and has demonstrated that testosterone increases muscle mass and strength; characterized testosterone’s dose response relationships and adverse effects, and elucidated the mechanisms by which testosterone increases muscle mass and stimulates erythropoiesis. His research has led to new applications of androgens and selective androgen receptor modulators.

Return to Top


David F.M. Brown

Dr. Brown is Professor of Emergency Medicine at Mass General Hospital where he serves as the inaugural Chair of the newly established Department of Emergency Medicine. Dr. Brown’s research focus is on cardiovascular emergencies. He has also led innovative work in emergency department process redesign which has been widely emulated.

Return to Top


Hyon K. Choi

Dr. Choi is Professor of Medicine at Massachusetts General Hospital where he serves as the Director of Clinical Epidemiology at the MGH Division of Rheumatology and the Director of the MGH Gout and Crystal Arthropathy Center. He is a leader in the epidemiologic and clinical study of inflammatory arthritis. His current research areas involve the genetics of gout, lifestyle interventions for gout, and developing methodological remedies for risk factor paradoxes in rheumatic conditions.

Return to Top


Lyn McDivitt Duncan

Dr. Duncan is Professor of Pathology at Mass General Hospital where she is the Director of Dermatopathology. Her research is focused on cutaneous oncology, which has resulted in increased diagnostic accuracy in discriminating benign mimics from malignant tumors. Her research in early stage melanoma has led to identifying novel prognostic markers and developing optimal sentinel lymph node analytical platforms and management algorithms.

Return to Top


Albert Edge

Dr. Edge is Professor of Otology and Laryngology at Massachusetts Eye and Ear where he is the Director of the Tillotson Cell Biology Unit. His research is focused on identifying and modulating molecular pathways in stem cell differentiation to neurons and mechanisms of cellular repair. His lab has recently shown that manipulating cellular signaling in progenitor cells in the cochlea can regenerate sensory hair cells after damage.

Return to Top


Leif Ellisen

Dr. Ellisen is Professor of Medicine at Mass General Hospital. He is the program director for Breast Oncology at MGH and co-leader of the Breast Cancer Program at the Dana-Farber/Harvard Cancer Center. Work in his lab has made major contributions to understanding how the p53 family of transcription factors contribute to normal development and cancer pathogenesis.

Return to Top


Laurence M. Epstein

Dr. Epstein is Professor of Medicine at Brigham and Women’s Hospital where he is the Chief of the Cardiac Arrhythmia Service and Director of the Electrophysiology Laboratory in the BWH Heart and Vascular Center. He is a pioneer in developing novel treatment options for cardiac arrhythmias. His clinical and research interest is currently focused on safe and effective pacemaker and ICD lead management, medical simulation and healthcare economics.

Return to Top


Alison E. Field

Dr. Field is Professor of Pediatrics at Boston Children’s Hospital and Professor in the Department of Epidemiology at the Harvard School of Public Health. She helped to establish the largest longitudinal pediatric cohort with frequent assessments of weight status and weight control behaviors. Her pioneering research on the epidemiology of eating disorders and obesity among adolescents and young adults has identified novel risk factors and is helping to change how these weight-related disorders are conceptualized.

Return to Top


Lisa V. Goodrich

Dr. Goodrich is Professor of Neurobiology at Harvard Medical School. She investigates how neurons acquire specialized properties during development, with a focus on the auditory system. Her lab has performed pioneering studies to learn how inner ear neurons are specified and wired to ensure faithful transmission of sound information from the ear to the brain.

Return to Top


Eva C. Guinan

Dr. Guinan is Professor of Radiation Oncology at the Dana-Farber Cancer Institute where she serves as the Department’s Director of Translation Research. She is a noted clinical and translational innovator in the field of stem cell transplantation. Her laboratory is currently focused on developing a novel and promising approach to human radiation mitigation and protection by modulating endotoxin-related innate immunity.

Return to Top


Francis J. Hornicek, Jr.

Dr. Hornicek is Professor of Orthopedic Surgery at Mass General Hospital where he is Chief of the Orthopaedic Oncology Service and co-leader of the Dana Farber/Harvard Cancer Center Sarcoma Group. His research is in the field of orthopedic oncology with a focus on heterotopic ossification, allograft transplantation, immunotherapy and outcomes research for musculoskeletal tumors. Dr. Hornicek’s basic science research has focused on aspects of cell biology and molecular biology of sarcomas.

Return to Top


Grant L. Iverson

Dr. Iverson is Professor of Physical Medicine and Rehabilitation at Spaulding Rehabilitation Hospital. He is the Director of the Sports Concussion Program at the Mass General Hospital for Children and the Associate Director of Traumatic Brain Injury for the Red Sox Foundation and MGH Home Base Program. He leads a multidisciplinary team investigating good and poor outcome from mild traumatic brain injury in athletes, civilians, active duty military service members and veterans.

Return to Top


Ashish K. Jha

Dr. Jha is Professor of Medicine at Brigham and Women’s Hospital and Professor of Health Policy Management at the Harvard School of Public Health where he is the Director of the Harvard Global Health Institute. He is a recognized leader in the study of costs and quality of the U.S. healthcare delivery system. He has done seminal work on key health policy interventions such as public reporting of provider performance, pay-for-performance, health information technology and the role of leadership in improving care.

Return to Top


S. Ananth Karumanchi

Dr. Karumanchi is Professor of Medicine at the Beth Israel Deaconess Medical Center. His laboratory has identified soluble mediators that cause preeclampsia, one of the most common medical complications of pregnancy. His team has also mechanistically linked preeclampsia to chronic maternal complications including hypothyroidism, chronic renal disease and peripartum cardiomyopathy.

Return to Top


Scott G. Kennedy

Dr. Kennedy is Professor of Genetics at Harvard Medical School. He and his colleagues are investigating how and why small non-coding RNAs modify chromatin landscapes and direct epigenetic inheritance in animals. Insights from their work may allow epigenetic states in humans to be regulated in such a way as to mitigate disease.

Return to Top


Ali Khademhosseini

Dr. Khademhosseini is Professor of Medicine at Brigham and Women’s Hospital where he is Director of the Biomaterials Innovation Research Center. He is recognized as a leader in combining micro- and nano-engineering approaches with advanced biomaterials for regenerative medicine applications. In particular, his laboratory has pioneered numerous microfabrication technologies for controlling the architecture and function of engineered vascularized tissues.

Return to Top


Lori Laffel

Dr. Laffel is Professor of Pediatrics at the Joslin Diabetes Center where she is Chief of the Pediatric, Adolescent, and Young Adult Section and a Senior Investigator in the Section on Genetics and Epidemiology. She, along with her clinical research team, has designed, implemented, and evaluated innovative approaches to improving adherence and outcomes for youth with diabetes. Her efforts focus on preserving health, preventing acute and chronic complications, and protecting the futures of young people with type 1 and type 2 diabetes.

Return to Top


Beate K.M. Lanske

Dr. Lanske is Professor of Oral Medicine, Infection and Immunity at the Harvard School of Dental Medicine where she co-directs the new “Research Academy” at the HSDM and the Forsyth Institute. Dr. Lanske studies endocrine regulation of mineral ion homeostasis by parathyroid glands, kidney and bone. Her laboratory has conducted innovative research using novel transgenic mouse models that have produced key insights, particularly regarding the importance of FGF23 and Klotho in regulating vitamin D and mineral ion homeostasis.

Return to Top


Elena Losina

Dr. Losina is Professor of Orthopedic Surgery at Brigham and Women’s Hospital where she is a co-Director of the Orthopaedic and Arthritis Center for Outcomes Research (OrACORe). She also directs the Statistical Center for Biomarkers Consortium, an international collaboration, to establish the prognostic value of biomarkers in osteoarthritis and leads a multi-sited project to conduct health policy evaluations related to surgical and non-surgical management of knee osteoarthritis. Dr. Losina’s contributions span multiple clinical disciplines, from orthopedics and osteoarthritis to global health and infectious diseases.

Return to Top


Richard Malley

Dr. Malley is Professor of Pediatrics at Boston Children’s Hospital. He is a recognized leader in the study of immunity to Streptococcus pneumoniae (pneumococcus). A main focus of his work is the development of novel vaccines against this and other common pediatric pathogens, for use in both developing and developed countries.

Return to Top


Madhusmita Misra

Dr. Misra is Professor of Pediatrics at Mass General Hospital, where she directs the fellowship program in Pediatric Endocrinology and also serves as the Associate Director of the Harvard Catalyst Clinical Research Center. She has worked extensively on neuroendocrine and bone alterations in conditions spanning the nutritional spectrum from anorexia nervosa to obesity and on characterizing the impact of nutritional status, exercise activity, hypogonadism and other hormonal changes on bone. She has contributed extensively to the field of adolescent bone accrual, which has led to therapeutic advances in treating low bone density in underweight girls.

Return to Top


Orhun Muratoglu

Dr. Muratoglu is Professor of Orthopedic Surgery at Mass General Hospital where he is the Co-Director of the Harris Orthopaedic Laboratory and Director of the Technology Implementation Research Center. He is a pioneer in the development of materials technologies for orthopaedic implants. Research by his group resulted in the discovery of highly-crosslinked load-bearing materials that have been implanted in over 4 million total joint patients.

Return to Top


Phillip L. Pearl

Dr. Pearl is Professor of Neurology at Boston Children’s Hospital. He is a recognized leader in inherited metabolic epilepsies as well as education in neurology. His research has focused on pediatric neurotransmitter disorders, with particular emphasis in disorders of GABA metabolism, including the characterization and first clinical trials of succinic semialdehyde dehydrogenase deficiency.

Return to Top


Olivier Pourquié

Dr. Pourquié, Ph.D. is Professor of Pathology and Genetics at Brigham and Women’s Hospital and Harvard Medical School. His laboratory provided the first evidence of the existence of a molecular oscillator – the segmentation clock – associated with the rhythmic production of vertebral precursors (the somites) in the embryo. His discoveries have had important consequences for our understanding of the patterning of the vertebrate embryonic axis and provided a conceptual framework to explain human spine malformations such as congenital scoliosis.

Return to Top


Eric B. Rimm

Dr. Rimm is Professor of Medicine at Brigham and Women’s Hospital and a Professor of Epidemiology and Nutrition at the Harvard School of Public Health where he serves as the Director of Cardiovascular Epidemiology. His research has focused on the cardiovascular benefits of diets high in whole grains, dietary fiber, polyphenols and alcohol in moderation. His work bridges our understanding of these relationships in large population studies with the biological pathways responsible for their benefit.

Return to Top


David C. Ring

Dr. David Ring is Professor of Orthopedic Surgery at Mass General Hospital. He also serves administratively as Chief of Hand Surgery and Chair of the Orthopedic Quality and Patient Safety Committee. He is renowned for his contributions to the understanding of upper extremity trauma and post-traumatic reconstruction, common arm illnesses, psychosocial aspects of arm illness and quality and patient safety.

Return to Top


James R. Rodrigue

Dr. Rodrigue is Professor of Psychology in the Department of Psychiatry at the Beth Israel Deaconess Medical Center where he is the Director of the Center for Transplant Outcomes & Quality Improvement. He is a recognized leader in the study of behavioral and psychological factors and their role in optimizing transplant outcomes and facilitating organ donation. His research group seeks to identify novel and effective clinical strategies for attenuating known racial and income disparities in transplantation.

Return to Top


Evan Rosen

Dr. Rosen is Professor of Medicine at the Beth Israel Deaconess Medical Center. His laboratory focuses on identifying the transcriptional and epigenomic events that affect metabolic function, with an emphasis on adipose tissue. His work has identified several key pathways that operate during normal adipocyte differentiation and physiology, in addition to factors that promote the metabolic dysregulation associated with obesity and diabetes.

Return to Top


David Z. Rudner

Dr. Rudner is Professor of Microbiology and Immunobiology at Harvard Medical School. He also chairs the HMS Biological and Biomedical Sciences graduate admissions committee. His work has made major contributions to understanding how bacteria communicate with each other, how they organize and segregate their chromosomes and how they remodel their cell envelope during growth and differentiation.

Return to Top


Jeremy N. Ruskin

Dr. Ruskin is Professor of Medicine at Mass General Hospital where he is the Director of the Cardiac Arrhythmia Service and the Clinical Cardiac Electrophysiology Fellowship Training Program. He established the first subspecialty service and training program dedicated to caring for patients with cardiac arrhythmias in New England. He is a pioneer in the field of clinical cardiac electrophysiology and has helped define the mechanisms and predictors of sudden cardiac death, optimizing the treatment of life threatening ventricular arrhythmias and developing new non-pharmacological approaches to managing atrial fibrillation.

Return to Top


Steven D. Schwaitzberg

Dr. Schwaitzberg is Professor of Surgery at the Cambridge Health Alliance where he is the Department Chief. He is a pioneer in the field of minimally invasive surgery and related technologies where his research in skills training and device/procedural development is well known. His current outcomes research is focused on novel and minimally invasive procedures.

Return to Top


Magdy H. Selim

Dr. Selim is a Professor of Neurology at the Beth Israel Deaconess Medical Center where he is the Chief of the division of Stroke & Cerebrovascular Disease. His clinical interest is centered on improving the treatment of stroke. He is specifically interested on the role of iron-mediated neurotoxicity following stroke and developing new therapies in particular for patients with intracerebral hemorrhage.

Return to Top


Ramesh A. Shivdasani

Dr. Shivdasani is Professor of Medicine at the Dana-Farber Cancer Institute and is Co-Director of the Cancer Program in the Harvard Stem Cell Institute. His work has made valuable contributions toward understanding the transcriptional basis for cell differentiation in two self-renewing tissues, namely blood and intestine. His lab investigates how transcription factors and chromatin interpret local signals to express tissue-specific genes in normal and cancer cells within the digestive tract.

Return to Top


Shamil R. Sunyaev

Dr. Sunyaev is Professor of Medicine at Brigham & Women’s Hospital. He has made major contributions to understanding human population genetic variation, especially population genetics of deleterious alleles. He has pioneered the development of computational methods for predicting the functional effect of human mutations and created statistical methods for the analysis of DNA sequencing data.

Return to Top


Brooke Swearingen

Dr. Swearingen is Professor of Neurosurgery at Mass General Hospital where he is the primary surgeon at the MGH Neuroendocrine Clinical Center. His research interest is focused on the management of pituitary disease and clinical outcomes following pituitary surgery. He has also had a significant impact on establishing standards for managing patients with disease of the pituitary including acromegaly and Cushing’s disease.

Return to Top


Sapna Syngal

Dr. Syngal is Professor of Medicine at the Dana-Farber Cancer Institute. She has established an internationally recognized clinical, research, and educational program devoted to the genetics and prevention of gastrointestinal malignancies. The results of her group’s work have helped define the clinical implications of novel etiologies for inherited colon cancer, demonstrated the benefits and complexities of genetic testing for hereditary gastrointestinal malignancies, and resulted in new risk assessment tools for inherited colorectal cancer that have become part of the standard of care.

Return to Top


William (Sandy) Wells, III

Dr. Wells is Professor of Radiology at Brigham and Women’s Hospital where he is the Chief Scientist in the BWH Surgical Planning Laboratory. He is widely known for his pioneering work in medical image segmentation and registration. He is currently investigating research in algorithms for image-guided therapy and general medical image analysis.

Return to Top

Comments are closed.